Marketing-authorisation holder · United States
Sinotherapeutics Inc
3 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| POSACONAZOLE100mg · Tablet, delayed release | Posaconazole | United States | Marketed | 2019 |
| DAPAGLIFLOZIN AND METFORMIN1000mg | 10mg | 500mg | 5mg · Tablet | Dapagliflozin, Metformin | United States | tentative | 2025 |
| SITAGLIPTIN AND METFORMIN HYDROCHLORIDE100mg | 500mg | 50mg · Tablet, extended release | Sitagliptin, Metformin | United States | tentative | 2025 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 3 | 1 | 2 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.